SKYSTAR Trademark

Trademark Overview

On Monday, September 17, 2018, a trademark application was filed for SKYSTAR with the United States Patent and Trademark Office. The USPTO has given the SKYSTAR trademark a serial number of 88976053. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, March 31, 2025. This trademark is owned by Skyhawk Therapeutics, Inc.. The SKYSTAR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals, namely, small molecule therapies for the correction of RNA expression, used in the treatment of cancers, neurological diseases, and other diseases
skystar

General Information

Serial Number88976053
Word MarkSKYSTAR
Filing DateMonday, September 17, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, March 31, 2025
Registration Number5922902
Registration DateTuesday, November 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 5, 2019

Trademark Statements

Pseudo MarkSKY STAR
Goods and ServicesResearch and development of pharmaceuticals, namely, small molecule therapies for the correction of RNA expression, used in the treatment of cancers, neurological diseases, and other diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 22, 2018
Primary Code042
First Use Anywhere DateSaturday, June 30, 2018
First Use In Commerce DateSaturday, June 30, 2018

Trademark Owner History

Party NameSkyhawk Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameSkyhawk Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameSkyhawk Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Saturday, September 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 20, 2018NEW APPLICATION ENTERED
Friday, December 28, 2018ASSIGNED TO EXAMINER
Friday, December 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 5, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 2, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, October 2, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, October 2, 2019TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, October 2, 2019SOU EXTENSION 1 FILED
Wednesday, October 2, 2019DIVISIONAL REQUEST RECEIVED
Monday, October 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 22, 2019SOU EXTENSION 1 GRANTED
Tuesday, October 22, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 23, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 2, 2019USE AMENDMENT FILED
Tuesday, October 22, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 22, 2019DIVISIONAL PROCESSING COMPLETE
Tuesday, November 26, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, February 20, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 20, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 12, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, March 31, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 31, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, March 31, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, November 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

skystar diseases treatment used cancers neurological other expression correction pharmaceuticals development